Scientific Letter
Effect of single-dose of tolvaptan in neurocritical patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion
Efecto de una dosis única de tolvaptán en pacientes neurocríticos con hiponatremia debido a SIADH
Leído
7926
Vecesse ha leído el artículo
3237
Total PDF
4689
Total HTML
Compartir estadísticas
array:24 [ "pii" => "S0210569116302613" "issn" => "02105691" "doi" => "10.1016/j.medin.2016.11.007" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "1009" "copyright" => "Elsevier España, S.L.U. y SEMICYUC" "copyrightAnyo" => "2016" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Med Intensiva. 2017;41:501-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2192 "formatos" => array:3 [ "EPUB" => 202 "HTML" => 1264 "PDF" => 726 ] ] "Traduccion" => array:1 [ "en" => array:19 [ "pii" => "S2173572717301753" "issn" => "21735727" "doi" => "10.1016/j.medine.2016.11.010" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "1009" "copyright" => "Elsevier España, S.L.U. and SEMICYUC" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Med Intensiva. 2017;41:501-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1558 "formatos" => array:3 [ "EPUB" => 169 "HTML" => 883 "PDF" => 506 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Effect of single-dose of tolvaptan in neurocritical patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "501" "paginaFinal" => "503" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Efecto de una dosis única de tolvaptán en pacientes neurocríticos con hiponatremia debido a SIADH" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1141 "Ancho" => 2460 "Tamanyo" => 115582 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Linear regression analysis of 24<span class="elsevierStyleHsp" style=""></span>h fluid balance and <span class="elsevierStyleItalic">Δ</span> natremia after the first dose of tolvaptan.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.A. Llompart-Pou, J. Pérez-Bárcena, M. Novo, J.M. Raurich" "autores" => array:4 [ 0 => array:2 [ "nombre" => "J.A." "apellidos" => "Llompart-Pou" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Pérez-Bárcena" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Novo" ] 3 => array:2 [ "nombre" => "J.M." "apellidos" => "Raurich" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0210569116302613" "doi" => "10.1016/j.medin.2016.11.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210569116302613?idApp=WMIE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572717301753?idApp=WMIE" "url" => "/21735727/0000004100000008/v1_201710301314/S2173572717301753/v1_201710301314/en/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S0210569117301808" "issn" => "02105691" "doi" => "10.1016/j.medin.2017.05.008" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "1078" "copyright" => "Elsevier España, S.L.U. y SEMICYUC" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Intensiva. 2017;41:504-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1897 "formatos" => array:3 [ "EPUB" => 171 "HTML" => 1021 "PDF" => 705 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">LETTER TO THE EDITOR</span>" "titulo" => "Antibiotic resistance: thinking outside the hospital" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "504" "paginaFinal" => "505" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Resistencia a antibióticos: pensando fuera del hospital" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A.J. Roldán-Reina, R. Martín-Bermúdez, Y. Corcia-Palomo, L. Martín-Villén" "autores" => array:4 [ 0 => array:2 [ "nombre" => "A.J." "apellidos" => "Roldán-Reina" ] 1 => array:2 [ "nombre" => "R." "apellidos" => "Martín-Bermúdez" ] 2 => array:2 [ "nombre" => "Y." "apellidos" => "Corcia-Palomo" ] 3 => array:2 [ "nombre" => "L." "apellidos" => "Martín-Villén" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173572717301789" "doi" => "10.1016/j.medine.2017.05.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572717301789?idApp=WMIE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210569117301808?idApp=WMIE" "url" => "/02105691/0000004100000008/v1_201710301105/S0210569117301808/v1_201710301105/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0210569116302418" "issn" => "02105691" "doi" => "10.1016/j.medin.2016.10.002" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "992" "copyright" => "Elsevier España, S.L.U. y SEMICYUC" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Med Intensiva. 2017;41:499-501" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3483 "formatos" => array:3 [ "EPUB" => 143 "HTML" => 2519 "PDF" => 821 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científica</span>" "titulo" => "Reversión de taquiarritmias supraventriculares tras la administración de propofol. Serie de casos" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "499" "paginaFinal" => "501" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Sinusal reversion of supraventricular tachyarrhythmias after propofol administration. A case series" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Montero-Tinnirello, M. Magaldi, J. Fontanals, P. Masgoret, J.C. Bravo" "autores" => array:5 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Montero-Tinnirello" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Magaldi" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Fontanals" ] 3 => array:2 [ "nombre" => "P." "apellidos" => "Masgoret" ] 4 => array:2 [ "nombre" => "J.C." "apellidos" => "Bravo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173572717301698" "doi" => "10.1016/j.medine.2017.08.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572717301698?idApp=WMIE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210569116302418?idApp=WMIE" "url" => "/02105691/0000004100000008/v1_201710301105/S0210569116302418/v1_201710301105/es/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Effect of single-dose of tolvaptan in neurocritical patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "501" "paginaFinal" => "503" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "J.A. Llompart-Pou, J. Pérez-Bárcena, M. Novo, J.M. Raurich" "autores" => array:4 [ 0 => array:4 [ "nombre" => "J.A." "apellidos" => "Llompart-Pou" "email" => array:1 [ 0 => "juanantonio.llompart@ssib.es" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "J." "apellidos" => "Pérez-Bárcena" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "M." "apellidos" => "Novo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "J.M." "apellidos" => "Raurich" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servei de Medicina Intensiva, Hospital Universitari Son Espases, Palma de Mallorca, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Instituto de Investigación Sanitaria de Palma (IdISPa), Palma de Mallorca, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Efecto de una dosis única de tolvaptán en pacientes neurocríticos con hiponatremia debido a SIADH" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1140 "Ancho" => 2460 "Tamanyo" => 129629 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Linear regression analysis of 24<span class="elsevierStyleHsp" style=""></span>h fluid balance and <span class="elsevierStyleItalic">Δ</span> natremia after the first dose of tolvaptan.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Hyponatremia constitutes the most common electrolyte abnormality found in patients with acquired brain injury,<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">1,2</span></a> being present in up to 20% of patients with traumatic brain injury (TBI) and 50% of patients with subarachnoid hemorrhage (SAH).<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">In most cases, the underlying cause of euvolemic hyponatremia in brain injured patients is the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">3</span></a> In this syndrome, an abnormal water/sodium handling is associated with an osmotic gradient that promotes the shift of water into brain cells, thereby worsening cerebral edema and resulting in deteriorating neurological condition with seizures, coma, increased intracranial pressure end eventually death.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">1,2,4</span></a> An appropriate correction of hyponatremia was associated with increased survival.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">5</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">In the recent years, tolvaptan, an orally active, selective, nonpeptide antagonist that blocks arginine vasopressin from binding to V2 receptors of the distal nephron inducing the excretion of electrolyte-free water (the so-called “aquaretic effect”) showed it effectiveness in the treatment of hyponatremia in randomized controlled trials,<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">6</span></a> but its use in neurocritically ill patients remains limited.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">2</span></a> Concerns with the potential risk of overcorrection and secondary osmotic demyelinating syndrome (ODS) arose, although the incidence of overcorrection can be even higher when using the commonly accepted 3% hypertonic saline.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">7</span></a> When tolvaptan is used, initial doses of 7.5 or 15<span class="elsevierStyleHsp" style=""></span>mg are recommended.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">8</span></a> Some authors recommend its use as a treatment of SIADH induced hyponatremia when first line therapies including fluid restriction have failed.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">9</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">In this report, we studied the effects of a single dose of tolvaptan in hyponatremic neurocritically ill patients.</p><p id="par0025" class="elsevierStylePara elsevierViewall">The study was approved by our Hospital Research Committee. The need of informed consent was waived due to the descriptive and retrospective nature of the study.</p><p id="par0125" class="elsevierStylePara elsevierViewall">All patients fulfilled the following definition of SIADH<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">1</span></a>:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><p id="par0030" class="elsevierStylePara elsevierViewall">Plasma sodium<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>135<span class="elsevierStyleHsp" style=""></span>mEq/L</p></li><li class="elsevierStyleListItem" id="lsti0010"><p id="par0035" class="elsevierStylePara elsevierViewall">Plasma osmolality<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>280<span class="elsevierStyleHsp" style=""></span>mOsm/kg of water</p></li><li class="elsevierStyleListItem" id="lsti0015"><p id="par0040" class="elsevierStylePara elsevierViewall">Urine osmolality<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>100<span class="elsevierStyleHsp" style=""></span>mOsm/kg of water</p></li><li class="elsevierStyleListItem" id="lsti0020"><p id="par0045" class="elsevierStylePara elsevierViewall">Urine sodium<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>40<span class="elsevierStyleHsp" style=""></span>mmol/L</p></li><li class="elsevierStyleListItem" id="lsti0025"><p id="par0050" class="elsevierStylePara elsevierViewall">Normal thyroid and adrenal function</p></li><li class="elsevierStyleListItem" id="lsti0030"><p id="par0055" class="elsevierStylePara elsevierViewall">Clinical euvolemia or hypervolemia</p></li><li class="elsevierStyleListItem" id="lsti0035"><p id="par0060" class="elsevierStylePara elsevierViewall">Absence of recent diuretics use</p></li></ul></p><p id="par0065" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Overcorrection</span> was defined when the Δ natremia was >8 mEq/L/24<span class="elsevierStyleHsp" style=""></span>h.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">1</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">We retrospectively analyzed the effect on the sodium levels and fluid balance in the first 24<span class="elsevierStyleHsp" style=""></span>h after tolvaptan was given. Quantitative data were reported as median (Interquartile Range (IQR) 25–75) and categorical data as number and percentage. Differences between natremia were compared using Mann–Whitney–Wilcoxon test and the association between 24<span class="elsevierStyleHsp" style=""></span>h fluid balance and <span class="elsevierStyleItalic">Δ</span> natremia using linear regression. A value of p<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05 was considered significant. Statistical analysis was performed with SPSS<span class="elsevierStyleSup">®</span> 20 (IBM Corporation 2011).</p><p id="par0075" class="elsevierStylePara elsevierViewall">Eight neurocritically ill patients admitted to our ICU fulfilled the above mentioned criteria of SIADH. During their ICU stay, all patients developed hyponatremia and were unsuccessfully treated with oral sodium chloride and 3% hypertonic saline. In such cases, an initial dose of 7.5<span class="elsevierStyleHsp" style=""></span>mg tolvaptan was given in the morning shift (in one patient 15<span class="elsevierStyleHsp" style=""></span>mg were administered). Of note, all patients increased their sodium levels and even in 3 patients (37.5%) no additional doses were deemed necessary. Only one patient (12.5%) presented overcorrection requiring treatment with intravenous dextrose and parenteral desmopressin. This patient received a 15<span class="elsevierStyleHsp" style=""></span>mg initial dose and had risk factors for ODS such as advanced liver disease and alcoholism. No clinical features of ODS were observed in the follow up.</p><p id="par0080" class="elsevierStylePara elsevierViewall">Baseline and clinical data in response to the administration of tolvaptan in the eight patients analyzed are shown (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). A moderate association between <span class="elsevierStyleItalic">Δ</span> Natremia and 24<span class="elsevierStyleHsp" style=""></span>h fluid balance was found (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.05) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).<span class="elsevierStyleVsp" style="height:0.5px"></span></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0085" class="elsevierStylePara elsevierViewall">Our results showed that a single 7.5<span class="elsevierStyleHsp" style=""></span>mg dose of tolvaptan was effective and safe in the treatment of hyponatremia due to SIADH in neurocritically ill patients. Some issues must be taking into consideration when evaluating our results:</p><p id="par0090" class="elsevierStylePara elsevierViewall">Tolvaptan resulted in an increase of sodium levels in all patients. The effect of a single dose of tolvaptan was enough to solve the hyponatremia in some cases, therefore minimizing the cost of the therapy. Follow up doses were used in 5 patients, when natremia decreased after the initial 48<span class="elsevierStyleHsp" style=""></span>h. An initial increase lasting 48<span class="elsevierStyleHsp" style=""></span>h has been previously described.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">2</span></a></p><p id="par0095" class="elsevierStylePara elsevierViewall">Due to the etiology of severe injury, our patients had limited access to water. Unlimited access to water was deemed mandatory to avoid secondary hypovolemia.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">10</span></a> We believe that in the ICU setting and with close monitoring of fluid balance and sodium levels, such requirement should not be considered necessary.</p><p id="par0100" class="elsevierStylePara elsevierViewall">Tolvaptan was safe at the 7.5<span class="elsevierStyleHsp" style=""></span>mg dose in all cases. The only episode of overcorrection occurred with a 15<span class="elsevierStyleHsp" style=""></span>mg dose in a patient with additional risk factors for overcorrection and ODS.<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">11</span></a> Related factors include advanced liver disease, malnourishment, hypophosphatemia, hypokalemia, etc.<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">11</span></a> We would recommend using the 7.5<span class="elsevierStyleHsp" style=""></span>mg dose for initiating tolvaptan in neurocritically ill patients. As stated, median <span class="elsevierStyleItalic">Δ</span> Natremia was 5 (4–8)<span class="elsevierStyleHsp" style=""></span>mEq/24<span class="elsevierStyleHsp" style=""></span>h in our sample. Moreover, we defined overcorrection as <span class="elsevierStyleItalic">Δ</span> natremia<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>8<span class="elsevierStyleHsp" style=""></span>mEq/L/24<span class="elsevierStyleHsp" style=""></span>h, but some authors would even accept <span class="elsevierStyleItalic">Δ</span> natremia 12<span class="elsevierStyleHsp" style=""></span>mEq/L/24<span class="elsevierStyleHsp" style=""></span>h safe in this setting.</p><p id="par0105" class="elsevierStylePara elsevierViewall">The main limitation of this preliminary study is the retrospective and observational design. In addition, the limited number of patients generates weakness in the linear regression analysis due to extreme values and precludes more complex analysis.</p><p id="par0110" class="elsevierStylePara elsevierViewall">In conclusion, in neurocritically ill patients, a low dose of 7.5<span class="elsevierStyleHsp" style=""></span>mg of tolvaptan was effective and safe in the treatment of hyponatremia due to SIADH. Future studies will determine its exact role in the management of hyponatremia in the whole ICU population. A prospective comparison with 3% hypertonic saline is necessary.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflict of interest</span><p id="par0115" class="elsevierStylePara elsevierViewall">Dr. Llompart-Pou declares having received honoraria from Otsuka for participating in a consensus document in the management of hyponatremia in critically ill patients.</p><p id="par0120" class="elsevierStylePara elsevierViewall">Dr. Pérez-Bárcena, Novo and Raurich declare no financial disclosure.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflict of interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1140 "Ancho" => 2460 "Tamanyo" => 129629 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Linear regression analysis of 24<span class="elsevierStyleHsp" style=""></span>h fluid balance and <span class="elsevierStyleItalic">Δ</span> natremia after the first dose of tolvaptan.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">ICH:</span> intracerebral hemorrhage; <span class="elsevierStyleItalic">TBI</span>: traumatic brain injury; <span class="elsevierStyleItalic">SAH:</span> subarachnoid hemorrhage.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Patient number \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Diagnosis \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Gender \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Age (years) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Day \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Natremia before tolvaptan \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Natremia 24<span class="elsevierStyleHsp" style=""></span>h after tolvaptan \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">Δ</span> Natremia<br>24<span class="elsevierStyleHsp" style=""></span>h \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Natremia 48<span class="elsevierStyleHsp" style=""></span>h after tolvaptan \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">24<span class="elsevierStyleHsp" style=""></span>h fluid balance (ml) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Follow up doses \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">ICH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">45 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">15 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">132 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">135 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">135 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−1440 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Yes \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">2<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">ICH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Female \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">55 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">11 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">127 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">142 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">15 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">139 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−3425 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">TBI \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Female \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">45 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">12 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">131 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">138 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">137 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−1850 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Yes \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">SAH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">48 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">21 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">132 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">137 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">136 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−122 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Yes \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">SAH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Female \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">57 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">133 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">138 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">136 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−744 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Yes \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Cerebral abcess \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">28 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">30 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">132 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">140 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">140 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−4372 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">SAH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">50 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">19 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">131 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">136 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">137 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−1726 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">TBI \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">29 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">25 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">134 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">136 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">136 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−456 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Yes \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Median (IQR) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">46 (33–54) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">17 (11–24) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">132 (131–133) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">138 (136–140) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5 (4–8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">136 (136–138) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−1600 (−3000 to −500) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1576655.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "*" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Means that this patient received a single 15<span class="elsevierStyleHsp" style=""></span>mg-dose.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Baseline and clinical data of the eight patients studied.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:11 [ 0 => array:3 [ "identificador" => "bib0060" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia in neurotrauma: the role of vasopressin" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Kleindienst" 1 => "M.J. Hannon" 2 => "M. Buchfelder" 3 => "J.G. Verbalis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/neu.2015.3981" "Revista" => array:6 [ "tituloSerie" => "J Neurotrauma" "fecha" => "2016" "volumen" => "33" "paginaInicial" => "615" "paginaFinal" => "624" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26472056" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0065" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of oral vasopressin V2 receptor antagonist for hyponatremia in acute brain injury" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.B. Jeon" 1 => "H.A. Choi" 2 => "C. Lesch" 3 => "M.C. Kim" 4 => "N. Badjatia" 5 => "J. Claassen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000350844" "Revista" => array:6 [ "tituloSerie" => "Eur Neurol" "fecha" => "2013" "volumen" => "70" "paginaInicial" => "142" "paginaFinal" => "148" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23887035" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0070" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical review: disorders of water homeostasis in neurosurgical patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.J. Hannon" 1 => "F.M. Finucane" 2 => "M. Sherlock" 3 => "A. Agha" 4 => "C.J. Thompson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2011-3201" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2012" "volumen" => "97" "paginaInicial" => "1423" "paginaFinal" => "1433" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22362821" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0075" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of hyponatremia on the brain" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Giuliani" 1 => "A. Peri" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/jcm3041163" "Revista" => array:6 [ "tituloSerie" => "J Clin Med" "fecha" => "2014" "volumen" => "3" "paginaInicial" => "1163" "paginaFinal" => "1177" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26237597" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0080" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "G. Corona" 1 => "C. Giuliani" 2 => "J.G. Verbalis" 3 => "G. Forti" 4 => "M. Maggi" 5 => "A. Peri" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0124105" "Revista" => array:5 [ "tituloSerie" => "PLOS ONE" "fecha" => "2015" "volumen" => "10" "paginaInicial" => "e0124105" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25905459" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0085" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "SALT Investigators" "etal" => true "autores" => array:6 [ 0 => "R.W. Schrier" 1 => "P. Gross" 2 => "M. Gheorghiade" 3 => "T. Berl" 4 => "J.G. Verbalis" 5 => "F.S. Czerwiec" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa065181" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2006" "volumen" => "355" "paginaInicial" => "2099" "paginaFinal" => "2112" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17105757" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0090" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosing and treating the syndrome of inappropriate antidiuretic hormone secretion" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.G. Verbalis" 1 => "A. Greenberg" 2 => "V. Burst" 3 => "J.P. Haymann" 4 => "G. Johannsson" 5 => "A. Peri" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjmed.2015.12.010" "Revista" => array:6 [ "tituloSerie" => "Am J Med" "fecha" => "2016" "volumen" => "129" "paginaInicial" => "537.e9" "paginaFinal" => "537.e23" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26763753" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0095" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.G. Verbalis" 1 => "S.R. Goldsmith" 2 => "A. Greenberg" 3 => "C. Korzelius" 4 => "R.W. Schrier" 5 => "R.H. Sterns" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjmed.2013.07.006" "Revista" => array:7 [ "tituloSerie" => "Am J Med" "fecha" => "2013" "volumen" => "126" "numero" => "10 Suppl. 1" "paginaInicial" => "S1" "paginaFinal" => "S42" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24074529" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0100" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "European Hyponatremia Network" "etal" => true "autores" => array:6 [ 0 => "I. Runkle" 1 => "C. Villabona" 2 => "A. Navarro" 3 => "A. Pose" 4 => "F. Formiga" 5 => "A. Tejedor" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2013" "volumen" => "141" "paginaInicial" => "507.e1" "paginaFinal" => "507.e10" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0105" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "<a href="http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000980/WC500048716.pdf">http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000980/WC500048716.pdf</a> [accessed 14.10.16]." ] ] ] 10 => array:3 [ "identificador" => "bib0110" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Central and extrapontine myelinolysis: then…and now" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B.K. Kleinschmidt-Demasters" 1 => "A.M. Rojiani" 2 => "C.M. Filley" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Neuropathol Exp Neurol" "fecha" => "2006" "volumen" => "65" "paginaInicial" => "1" "paginaFinal" => "11" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16410743" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/02105691/0000004100000008/v1_201710301105/S0210569116302613/v1_201710301105/en/main.assets" "Apartado" => array:4 [ "identificador" => "19505" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas Científicas" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02105691/0000004100000008/v1_201710301105/S0210569116302613/v1_201710301105/en/main.pdf?idApp=WMIE&text.app=https://medintensiva.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210569116302613?idApp=WMIE" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 3 | 8 | 11 |
| 2024 Octubre | 73 | 83 | 156 |
| 2024 Septiembre | 87 | 60 | 147 |
| 2024 Agosto | 79 | 64 | 143 |
| 2024 Julio | 91 | 41 | 132 |
| 2024 Junio | 108 | 78 | 186 |
| 2024 Mayo | 61 | 69 | 130 |
| 2024 Abril | 69 | 57 | 126 |
| 2024 Marzo | 69 | 35 | 104 |
| 2024 Febrero | 53 | 32 | 85 |
| 2024 Enero | 41 | 31 | 72 |
| 2023 Diciembre | 44 | 36 | 80 |
| 2023 Noviembre | 48 | 49 | 97 |
| 2023 Octubre | 72 | 46 | 118 |
| 2023 Septiembre | 42 | 48 | 90 |
| 2023 Agosto | 55 | 17 | 72 |
| 2023 Julio | 56 | 28 | 84 |
| 2023 Junio | 46 | 18 | 64 |
| 2023 Mayo | 49 | 31 | 80 |
| 2023 Abril | 38 | 24 | 62 |
| 2023 Marzo | 72 | 45 | 117 |
| 2023 Febrero | 70 | 31 | 101 |
| 2023 Enero | 44 | 23 | 67 |
| 2022 Diciembre | 82 | 48 | 130 |
| 2022 Noviembre | 61 | 44 | 105 |
| 2022 Octubre | 91 | 38 | 129 |
| 2022 Septiembre | 72 | 35 | 107 |
| 2022 Agosto | 76 | 47 | 123 |
| 2022 Julio | 54 | 63 | 117 |
| 2022 Junio | 65 | 43 | 108 |
| 2022 Mayo | 78 | 37 | 115 |
| 2022 Abril | 112 | 60 | 172 |
| 2022 Marzo | 100 | 65 | 165 |
| 2022 Febrero | 67 | 40 | 107 |
| 2022 Enero | 55 | 51 | 106 |
| 2021 Diciembre | 64 | 52 | 116 |
| 2021 Noviembre | 62 | 52 | 114 |
| 2021 Octubre | 69 | 83 | 152 |
| 2021 Septiembre | 54 | 41 | 95 |
| 2021 Agosto | 48 | 61 | 109 |
| 2021 Julio | 26 | 52 | 78 |
| 2021 Junio | 56 | 47 | 103 |
| 2021 Mayo | 54 | 58 | 112 |
| 2021 Abril | 132 | 89 | 221 |
| 2021 Marzo | 71 | 41 | 112 |
| 2021 Febrero | 47 | 43 | 90 |
| 2021 Enero | 60 | 49 | 109 |
| 2020 Diciembre | 49 | 50 | 99 |
| 2020 Noviembre | 35 | 37 | 72 |
| 2020 Octubre | 48 | 37 | 85 |
| 2020 Septiembre | 36 | 38 | 74 |
| 2020 Agosto | 39 | 30 | 69 |
| 2020 Julio | 36 | 33 | 69 |
| 2020 Junio | 44 | 27 | 71 |
| 2020 Mayo | 31 | 19 | 50 |
| 2020 Abril | 50 | 24 | 74 |
| 2020 Marzo | 14 | 10 | 24 |
| 2020 Febrero | 40 | 35 | 75 |
| 2020 Enero | 41 | 30 | 71 |
| 2019 Diciembre | 39 | 31 | 70 |
| 2019 Noviembre | 43 | 34 | 77 |
| 2019 Octubre | 47 | 20 | 67 |
| 2019 Septiembre | 37 | 26 | 63 |
| 2019 Agosto | 38 | 15 | 53 |
| 2019 Julio | 36 | 42 | 78 |
| 2019 Junio | 32 | 21 | 53 |
| 2019 Mayo | 58 | 42 | 100 |
| 2019 Abril | 19 | 16 | 35 |
| 2019 Marzo | 28 | 39 | 67 |
| 2019 Febrero | 41 | 36 | 77 |
| 2019 Enero | 42 | 43 | 85 |
| 2018 Diciembre | 65 | 58 | 123 |
| 2018 Noviembre | 123 | 54 | 177 |
| 2018 Octubre | 139 | 35 | 174 |
| 2018 Septiembre | 65 | 15 | 80 |
| 2018 Agosto | 40 | 20 | 60 |
| 2018 Julio | 58 | 19 | 77 |
| 2018 Junio | 69 | 23 | 92 |
| 2018 Mayo | 43 | 13 | 56 |
| 2018 Abril | 44 | 19 | 63 |
| 2018 Marzo | 59 | 26 | 85 |
| 2018 Febrero | 15 | 3 | 18 |
| 2018 Enero | 0 | 1 | 1 |
| 2017 Diciembre | 4 | 3 | 7 |
| 2017 Noviembre | 16 | 14 | 30 |
| 2017 Octubre | 0 | 1 | 1 |
| 2017 Julio | 0 | 1 | 1 |
| 2017 Marzo | 0 | 1 | 1 |
| 2017 Febrero | 0 | 1 | 1 |
| 2017 Enero | 0 | 2 | 2 |
Mostrar todo
